𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of cytosar in pediatric acute myelocytic leukemia and leukemic meningitis

✍ Scribed by Sullivan, Margaret P.

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
368 KB
Volume
10
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of cytosar in pediatric non-Hodgkin
Use of cytosar in pediatric non-Hodgkin lymphoma
✍ Sullivan, M. P. ;Ramirez, I. ;Pullen, J. ;Moore, T. ;Doering, E. J. ;Falletta, J πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 320 KB

Cytosar, as a component of LSAz-Lz therapy, was given in combination with thioguanine in consolidation by schedules used in acute granulocytic leukemia. Daily Cytosar injections were given for 4 days in maintenance. In an effort to increase efficacy, second generation LSAz-Lz therapy employs Cytosar

High terminal deoxynucleotidyl transfera
High terminal deoxynucleotidyl transferase activity in pediatric patients with acute lymphocytic and acute myelocytic leukemias
✍ B. I. Sahai Srivastava; Sohaib A. Khan; Jun Minowada; Arnold Freeman πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 French βš– 517 KB

## Abstract Specificity of TdT^5^ as a marker for ALL was evaluated by determining its activity in cells from normal control subjects and from 35 pediatric patients with ALL, AML, Hodgkin's disease and disseminated Burkitt's lymphoma. We evaluated the DNA polymerase activity, cell surface pheno‐typ

Failure of remission induction in acute
Failure of remission induction in acute myelocytic leukemia
✍ Preisler, Harvey D. πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Preisler Reporting of clinical failures using this schema would focus attention on the mechanism of treatment failure and hence lead t o logically derived successor studies For example, given two therapeutic regimens each of which produces a 50% complete remission rate, if tlie failures in one